These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37000552)

  • 1. Interventions designed to improve uptake of allopurinol for gout treatment in Aotearoa New Zealand: a scoping review.
    Ofanoa S; Ofanoa M; Tu'akoi S; Lutui H; Heather M; Jansen RM; Dalbeth N; Grey C; Goodyear-Smith F
    J Prim Health Care; 2023 Mar; 15(1):48-58. PubMed ID: 37000552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in gout care in Aotearoa New Zealand: a national analysis of quality markers.
    Jackson G; Dalbeth N; Te Karu L; Winnard D; Gow P; Gerard C; Minko N
    N Z Med J; 2014 Oct; 127(1404):37-47. PubMed ID: 25331310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitating equitable prevention and management of gout for Māori in Northland, New Zealand, through a collaborative primary care approach.
    Lawrence A; Scott S; Saparelli F; Greville G; Miller A; Taylor A; Gow P
    J Prim Health Care; 2019 Jul; 11(2):117-127. PubMed ID: 32171354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of care in people requiring hospital admission for gout in Aotearoa New Zealand: a nationwide analysis.
    Murdoch R; Jones P; Greenwell J; Dalbeth N
    Intern Med J; 2022 Dec; 52(12):2136-2142. PubMed ID: 34339089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and implementation of a Pacific intervention to increase uptake of urate-lowering therapy for gout: a study protocol.
    Ofanoa M; Ofanoa SM; Heather M; Tu'akoi S; Lutui H; Dalbeth N; Grey C; van der Werf B; Goodyear-Smith F
    Int J Equity Health; 2021 Dec; 20(1):262. PubMed ID: 34949187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National prevalence of gout derived from administrative health data in Aotearoa New Zealand.
    Winnard D; Wright C; Taylor WJ; Jackson G; Te Karu L; Gow PJ; Arroll B; Thornley S; Gribben B; Dalbeth N
    Rheumatology (Oxford); 2012 May; 51(5):901-9. PubMed ID: 22253023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential unmet need for gout diagnosis and treatment: capture-recapture analysis of a national administrative dataset.
    Jackson G; Wright C; Thornley S; Taylor WJ; Te Karu L; Gow PJ; Arroll B; Gribben B; Dalbeth N; Winnard D
    Rheumatology (Oxford); 2012 Oct; 51(10):1820-4. PubMed ID: 22723595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand.
    Stamp LK; Haslett J; Frampton C; White D; Gardner D; Stebbings S; Taylor G; Grainger R; Kumar R; Kumar S; Kain T; Porter D; Corkill M; Cathro A; Metcalfe S; Wyeth J; Dalbeth N
    Intern Med J; 2016 Sep; 46(9):1075-80. PubMed ID: 27391386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allopurinol use in a New Zealand population: prevalence and adherence.
    Horsburgh S; Norris P; Becket G; Arroll B; Crampton P; Cumming J; Keown S; Herbison P
    Rheumatol Int; 2014 Jul; 34(7):963-70. PubMed ID: 24390636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uricosuric medications for chronic gout.
    Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the use of allopurinol in chronic gout: monitoring oxypurinol levels to guide therapy.
    Keith MP; Gilliland WR
    Clin Pharmacol Ther; 2011 Sep; 90(3):363-4. PubMed ID: 21862966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.
    Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R
    J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum urate levels and therapy in adults treated with long-term dialysis: a retrospective cross-sectional study.
    Yeo E; Palmer SC; Chapman PT; Frampton C; Stamp LK
    Intern Med J; 2019 Jul; 49(7):838-842. PubMed ID: 30426652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febuxostat for treating chronic gout.
    Tayar JH; Lopez-Olivo MA; Suarez-Almazor ME
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD008653. PubMed ID: 23152264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A model-based meta-analysis to compare urate-lowering response rate of febuxostat and allopurinol in gout patient].
    Sun Y; Li L; Zhou TY; Lu W
    Yao Xue Xue Bao; 2014 Dec; 49(12):1674-83. PubMed ID: 25920196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis.
    Castrejon I; Toledano E; Rosario MP; Loza E; Pérez-Ruiz F; Carmona L
    Rheumatol Int; 2015 Jul; 35(7):1127-37. PubMed ID: 25519877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does starting allopurinol prolong acute treated gout? A randomized clinical trial.
    Hill EM; Sky K; Sit M; Collamer A; Higgs J
    J Clin Rheumatol; 2015 Apr; 21(3):120-5. PubMed ID: 25807090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence and persistence to urate-lowering therapies in the Irish setting.
    McGowan B; Bennett K; Silke C; Whelan B
    Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial.
    Mikuls TR; Cheetham TC; Levy GD; Rashid N; Kerimian A; Low KJ; Coburn BW; Redden DT; Saag KG; Foster PJ; Chen L; Curtis JR
    Am J Med; 2019 Mar; 132(3):354-361. PubMed ID: 30503879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of an electronic patient-centred self-management tool for gout sufferers: a cluster randomised controlled trial protocol.
    Day RO; Frensham LJ; Nguyen AD; Baysari MT; Aung E; Lau AYS; Zwar N; Reath J; Laba T; Li L; McLachlan A; Runciman WB; Buchbinder R; Clay-Williams R; Coiera E; Braithwaite J; McNeil HP; Hunter DJ; Pile KD; Portek I; WIlliams KM; Westbrook JI
    BMJ Open; 2017 Oct; 7(10):e017281. PubMed ID: 29042386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.